[SP600125-induced polyploidization of megakaryocytic leukemia cell lines by ribosomal protein S6 kinase 1 depends on the degree of cell differentiation].
Objective To investigate regulatory role of ribosomal protein S6 kinase 1 (S6K1) in the polyploidization of different megakaryocytic leukemia cell lines at the different differentiation stages. Methods Megakaryocytic leukemia cell lines (Dami, Meg-01 and HEL cells) were induced towards polyploidization by SP600125, a c-Jun N-terminal kinase (JNK) inhibitor. The SP600125-inducing process was blocked by H-89, a cAMP-dependent protein kinase (PKA) inhibitor. The phenotype (CD41a, CD42a and CD42b) and DNA ploidy were detected by flow cytometry. The expression and phosphorylation of S6K1 and related proteins were detected by Western blotting. Results SP600125 induced polyploidization and increased the phosphorylation of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) in Dami, Meg-01 and HEL cells. However, the effect of SP600125 on polyploidization of the three cell lines was different, with the strongest effect on Dami cells and the weakest on Meg-01 cells. Moreover, SP600125 increased the phosphorylation of S6K1 Thr421/Ser424 and decreased the phosphorylation of Thr389 in Dami cells. However, it only increased the phosphorylation of Thr389 in HEL cells and had no effect on the phosphorylation of S6K1 in Meg-01 cells. Interestingly, H-89 only partially blocked the polyploidization of Dami cells, although it decreased the phosphorylation of 4E-BP1 in all SP600125-induced three cell lines. Noticeably, H-89 decreased the phosphorylation of S6K1 Thr421/Ser424 and increased the phosphorylation of Thr389 in Dami cells. However, H-89 had no effect on the phosphorylation of Thr421/Ser424, although it increased the phosphorylation of Thr389 in Meg-01 and HEL cells. Phenotypic analysis showed that the three cell lines were at different levels of differentiation in megakaryocytic lineage, with the highest differentiation in Dami and the lowest in Meg-01 cells. Conclusion SP600125-induced polyploidization of megakaryocytic leukemia cell lines is dependent on the effect of SP600125 on phosphorylation of S6K1 in cell lines at the different differentiation stages.
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China.
Lili
L
Wang
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China.
Jingang
J
Yang
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China.
Changling
C
Li
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China.
Sining
S
Xing
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China.
Ying
Y
Yu
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China.
Shuo
S
Liu
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China.
Song
S
Zhao
Department of Experimental Medicine, Northern Hospital, Shenyang Military Area Command, Shenyang 110016, China. *Corresponding author, E-mail: mdc580819@sina.com.
Dongchu
D
Ma
D000873:Anthracenes / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D007947:Leukemia, Megakaryoblastic, Acute / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D008533:Megakaryocytes / Q000166:cytology* / Q000201:enzymology; D010766:Phosphorylation; D011123:Polyploidy; D019893:Ribosomal Protein S6 Kinases / Q000235:genetics / Q000378:metabolism*; D013449:Sulfonamides / Q000494:pharmacology
D000873:Anthracenes; D007546:Isoquinolines; D013449:Sulfonamides; C432165:pyrazolanthrone; D019893:Ribosomal Protein S6 Kinases; C063509:N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide